WASHINGTON - A federal judge's decision last week to suspend the U.S. Food and Drug Administration's approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said.
Some said it could also lead drugmakers to stick to treatments perceived as safe investments and shy away from those that might get caught up in politically charged legal cases. The challenge was brought by a coalition of anti-abortion groups and doctors seeking withdrawal of the FDA's mifepristone approval before Kacsmaryk, who is himself a conservative former Christian activist.Kacsmaryk ordered mifepristone pulled from the market while he considers a final ruling, but stayed the order for a week in order to give the government a chance to file an emergency appeal, which it did.
Plaintiffs are arguing that the FDA in its 2000 approval did not adequately consider the drug's safety when used by girls under age 18 to terminate a pregnancy.
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: chicagotribune - 🏆 8. / 91 Read more »